Publisher
Springer International Publishing
Reference96 articles.
1. Genkins G, Kornfeld P, Papatestas AE, Bender AN, Matta RJ. Clinical experience in more than 2000 patients with myasthenia gravis. Ann N Y Acad Sci. 1987;505:500–13.
2. Dalakas MC. Treatment and management of autoimmune myopathies. In: Bertorini TE, editor. Neuromuscular disorders. Philadelphia: Elsevier Saunders; 2010. p. 395–408.
3. Tsokos GC, Goust J-M, Virella G. Pathogenic factors involved in the onset of autoimmune disease. In: Virella G, editor. Medical immunology. 5th ed. New York: CRC Press; 2001. p. 393–7.
4. Lechner-Scott J, Spencer B, de Malmanche T, Attia J, Fitzgerald M, Trojano M, et al. MSBase study group. The frequency of CSF oligoclonal banding in multiple sclerosis increases with latitude. Mult Scler. 2012;18:974–82.
5. Loma I, Heyman R. Multiple sclerosis: pathogenesis and treatment. Curr Neuropharmacol. 2011;9(3):409–16.